The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Plasma triglyceride and coronary heart disease
Open accessAbstract
Although the literature on epidemiological associations between plasma triglyceride and CHD is not completely consistent, trends do emerge from the studies described here. First, the majority of observational studies demonstrate a significant univariate relation, although the results of case-control and cross-sectional studies are more uniform than those from prospective study designs. In many but not all studies, triglyceride remains a significant predictor of CHD in multivariate statistical analyses after controlling for TC or LDL-C. Perhaps the least consistent result is that the triglyceride association does not persist in some analyses controlling for HDL-C, while in other studies, the association remains significant. Although most studies have been conducted in men, the studies providing data on women, normocholesterolemic subjects, and diabetic subjects have generally found triglyceride to be, at the very least, a univariate risk factor. The results of intervention trials differ considerably, but no such study to date has been specifically designed to evaluate triglyceride-lowering effects on primary prevention of CHD. Important statistical properties must be taken into consideration in evaluating triglyceride as a risk factor for CHD. The large variability of triglyceride measurements and the correlation of triglyceride values with other lipid measures appears to result in the underestimation of the association between triglyceride and disease in multivariate analyses. Finally, individual genetic susceptibility may play an important role in the relation between plasma triglyceride levels and CHD. For example, risk of CHD clearly varies among the well-established familial forms of hypertriglyceridemia. A predominance of small, dense, LDL particles (LDL subclass pattern B) also appears to be a genetic trait associated with both increased risk of MI and increases in plasma triglyceride levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis.”
In the citing paper
“Over the past three decades, epidemiologic and genetic evidence has accumulated to support the concept that elevated levels of plasma TG, TRL, and TRL remnants are causally related to an increased risk of ASCVD-related events—myocardial infarction (MI), stroke, and aortic valve stenosis—and all-cause mortality.1,2,17,19,20,24–28”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Self-citationMorbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
Garcia, M. J., McNamara, P. M., Gordon, T., & Kannell, W. B. (1974) · Diabetes · doi:10.2337/diab.23.2.105 · Cited by 1,608
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,444
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Self-citation
Research works printed but not linked: 26
- [2]2. National Heart, Lung, and Blood Institute Consensus Development Panel: Treatment of hypertriglyceridemia. JAMA 1984;251:1196-1200
- [15]15. factors in relation to acute myocardial infarction. Arteriosclerosis 1981;1:273-279
- [30]30. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR: Is the level of serum triglyceride a it,, ot f oo teir olemic" subjects? The Paris Prospective Study. Am J Epidemiol 1986;124:624-632
- [29]29. Carlson LA, Böttiger LÈ: Risk factors for ischaemic heart disease in men and women. Acta Med Scand 1985;218:207–211
- [32]32. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangiwala S: Triglycerides and coronary heart disease mortality: The Lipid Research Clinics Follow-up Study. Atheroscler Rev (in press)
- [34]34. Pocock SJ, Shaper AG, Phillips AN: Concentrations of high density lipoprotein cholesterol, triglyceride and total cholesterol in ischaemic heart disease. Br Med J 1989;298:998–1002
- [37]37. Wilson PF: The impact of triglycerides on coronary heart disease: The Framingham Study. Atherosclerosis Rev (in press)
- [4]4. Scand Suppl 1973;549:51–59
- [46]46. Salel AF, Riggs K, Mason DT, Amsterdam EA, Zelis R: The impdsie rea psie ia p psng factor in coronary artery disease. Am J Med 1974;57:897–903
- [50]50. Jenkins PJ, Harper RW, Nestel PJ: Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 1978;2:388-391
- [53]53. Wieland H, Seidel D, Wiegand V, Kreuzer H: Serum lipoproteins and coronary artery disease (CAD). Atherosclerosis 1980;36:269-280
- [55]55. Holmes DR Jr, Elveback LR, Frye RL, Kottke BA, Ellefson RD: Association of risk factor variables and coronary artery disease documented with angiography. Circulation 1981;63: 293-299
- [58]58. Reardon MF, Nestel PJ, Craig IH, Harper RW: Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881-888
- [64]64. Santen RJ, Willis PW, Fajaris SS: Atherosclerosis in diabetes mellitus: Correlations with lipid levels, adiposity and serum insulin level. Arch Intern Med 1972;130:833–843
- [66]66. Janka HU: Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl Series 1985;15:15-19
- [71]71. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-374
- [77]77. Kelsey J, Thompson WD, Evans AS: Methods in Observational Epidemiology. New York, Oxford University Press, 1986, pp 293–297
- [84]84. Davis CE, Kim H: Is triglyceride an independent risk factor for CHD? Circulation 1990;81:14
- [88]88. Childs B: Introduction, in Childs B, Holtzman NA, Kazazian HH, Valle DL (eds): Molecular Genetics in Medicine. Progress in Medical Genetics, New Series, Vol 7. New York, Elsevier, 1988, Pp 1-16
- [93]93. Mahley RW, Innerarity TL, Rall SC Jr, Weisbraber KH: Lipoproteins of special significance in atherosclerosis: Insights provided by studies of Type III hyperlipidemia. Ann N Y Acad Sci 1986;485:209–221
- [92]92. Sane T, Nikkila EA: Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Arteriosclerosis 1987;8:217–226
- [97]97. Shen MMS, Krauss RM, Lindgren FT, Forte TM: Heterogeneity of serum low density lipoproteins in normal subjects. J Lipid Res 1981;22:236–244
- [99]99. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoproteins, In Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181–274
- [101]101. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ: Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. J Clin Invest 1984;74:470–482
- [102]102. Nichols AV, Krauss RM, Musliner TA: Nondenaturing polyacrylamide gradient gel electrophoresis, In Segrest JP, Albers JJ (eds): Methods in Enzymology, Plasma Lipoproteins. Part A. Preparation, Structure and Molecular Biology. Orlando, Fla, Academic Press, Inc, 1986, vol 41, pp 417–431
- [110]110. Gianturco SH, Bradley WA: A cellular basis for the atherogenicity of triglyceride-risk lipoproteins. Atherosclerosis Rev (in press)
Cited by
Sorted by citations
Items 601–696 of 696
Function and significance of very low density lipoprotein receptor subtype II
Jun, T., Hao, B., Ying-hong, L., Yang, P., Yiqiang, Z., Wang, Y., & Qu, S. (2005) · Current Medical Science · doi:10.1007/bf02828127 · Cited by 2
Bubnova, M. G., Ezhov, M. V., Aronov, D. M., Galyаvich, A. S., Gurevich, V. S., Duplyakov, D. V., Zafiraki, V. K., Karamnova, N. S., Kashtalap, V. V., Konovalov, G. A., et al. (2025) · Cardiosomatics · doi:10.17816/cs688224 · Cited by 1
Cell apoptosis in ischemic stroke: Focus on lipid metabolism
Sun, R., Yang, W., Zhao, Y., Zhang, F., Wu, G., Wang, A., & Tian, Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00301 · Cited by 1
“DHA accumulates in phospholipids that form the cell membranes of astrocytes and nerve cells on both sides of the BBB. DHA crosses the BBB into the brain parenchyma via the BBB-specific lipid transport protein major facilitator superfamily domain containing 2a (MFSD2A) and fatty acid-binding protein 5 (FABP5).”
InfluentialMetabolic aspects of polycystic ovary syndrome
Wild, R. A. (1997) · Reproductive Medicine Review · doi:10.1017/s0962279900001423 · Cited by 1
Ohta, Y., Kawano, Y., Iwashima, Y., Hayashi, S., Yoshihara, F., & Nakamura, S. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.64 · Cited by 1
Perfíl lipídico en una comunidad de Calarcá, Colombia
Arias, A., Castillo, M., Landázuri, P., Restrepo, B., & Betancourth, M. L. G. (1997) · Biomédica · doi:10.7705/biomedica.v17i3.952 · Cited by 1
Effects of Pyroligneous Liquor on Olive, Flaxseed and Perilla Oils in Lipid Metabolism of Mice
Chung, K. H., 방남휴, Shin, K.-O., Jung, T., Hwang, H., & Choi, K.-S. (2013) · The Korean Journal of Food And Nutrition · doi:10.9799/ksfan.2013.26.2.242 · Cited by 1
Healthy Food Versus Phytosterol-Fortified Foods for Primary Prevention of Coronary Artery Disease
Meskin, M. S., Bidlack, W. R., Davies, A. J., Lewis, D. S., & Randolph, R. K. (2003) · CRC Press eBooks · doi:10.1201/9780203506332-13 · Cited by 1
Traditional Risk Factors and Newly Recognized Emerging Risk Factors for Cardiovascular Disease
Diseases, H. O. I. (2003) · Springer eBooks · doi:10.1007/0-306-47926-5_3 · Cited by 1
Effects of Experimentally Induced Nicotine on the Liver of Neonatal Albino Rat
Marzouk, H. S., Awaad, A. S., Abo‐Eleneen, R. E., & El-Bakry, A. M. (2021) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2022/10.1.151.159 · Cited by 1
Pooja, X., Rana, M. D., & Rana, A. J. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23920134455 · Cited by 1
Óleo de pequi (Caryocar coriaceum W.) e a potencial atividade cardioprotetora
Kerntopf, M. R., de Figueiredo, P. R. L., Felipe, C. F. B., Almeida, W. D. O., de Menezes, I. R. A., Fernandes, G. P., & Lemos, I. C. S. (2013) · Ensaios e Ciência C Biológicas Agrárias e da Saúde · doi:10.17921/1415-6938.2013v17n4p%p · Cited by 1
Effects of Fish Oil on Risk Factors for Cardiovascular Disease
Haglund, O. (1993) · Upsala Journal of Medical Sciences · doi:10.3109/03009739309179307 · Cited by 1
Role of Lipids in Progressive Renal Disease: Insights from the Analbuminemic Rat
Joles, J. A., Rabelink, T. J., & Koomans, H. A. (1997) · KARGER eBooks · doi:10.1159/000059830 · Cited by 1
Die Wirkung von VLDL-Isoformen auf die flussabhängige Dilatation an Koronararterien des Menschen
Schlangen, J. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15060 · Cited by 1
Factors Influencing the Altered Lipoprotein System in Hypertriglyceridemia
Taskinen, M.-R. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_55 · Cited by 1
Li, J., Kondo, A., Kanno, T., & Maekawa, M. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.198 · Cited by 1
“Plasma high-density lipoprotein-cholesterol (HDL-C) and TG levels have been implicated in the pathogenesis of atherosclerosis (7, 8).”
BackgroundJones, P. H. (1996) · Endocrine Practice · doi:10.4158/ep.2.1.30 · Cited by 1
Treatment Is Indicated because of the Risk of Accelerated Atherosclerosis
Brunzell, J. D., & Davis, C. L. (1993) · Seminars in Dialysis · doi:10.1111/j.1525-139x.1993.tb00296.x · Cited by 1
Factores de riesgo cardiovascular la obesidad
Matamoros, P., Rubio, M. Á., Gutierrez, J. A., & Fernández, C. (2001) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(01)74384-7 · Cited by 1
SAKUMA, N., Ikeuchi, R., Hibino, T., Ohte, N., Tamai, N., Kamiya, T., & Kimura, G. (2002) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.31.37 · Cited by 1
“Hypertriglyceridemia, a risk factor for coronary heart disease [1], may be related to a”
BackgroundDietary fat composition and cardiovascular disease
Minihane, A. M. (2006) · Food Science & Technology Bulletin Functional Foods · doi:10.1616/1476-2137.14369 · Cited by 1
Ikeuchi, R., SAKUMA, N., Hasegawa, Y., Hibino, T., Yoneyama, A., Tamai, N., Sasai, K., & Yoshimata, T. (1997) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23.187 · Cited by 1
“Hypertriglyceridemia is a risk factor that is associated with ischemic heart disease [1, 2].”
BackgroundRationale for Cholesterollowering Strategies
Grundy, S. M., & Friedman, D. E. (1995) · Current Problems in Cardiology · doi:10.1016/s0146-2806(06)80016-2 · Cited by 1
An update on the cellular basis of atherosclerosis in hypertriglyceridemia
Ramprasad, M. P. (1995) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02873660 · Cited by 1
Rubió, P. P. (2002) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(02)78831-1 · Cited by 1
Ohmichi, M., Ikegami, H., Kurachi, H., Node, K., Morishige, K., Nishio, Y., Adachi, K., Matumoto, K., Hayakawa, J., Tasaka, K., et al. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00223-1 · Cited by 1
“In addition, patients with hypertriglyceridemia, in whom the incidence of heart disease is increased, tend to have low HDL-C concentrations [27], whereas estrogen-induced hypertriglyceridemia is associated with a concomitant increase in HDL-C.”
BackgroundPownall, H. J., Brauchi, D., Kılınç, C., Ballantyne, C. M., McKeone, B. J., Osmundsen, K., Pao, Q., & Gotto, A. M. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_79 · Cited by 1
Obesity and Dyslipidaemia: Importance of Body Fat Distribution
Tchernof, A., & Després, J. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch12 · Cited by 1
Treatment of and Screening for Hyperlipidemia
Ornish, D., & Brown, S. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291515 · Cited by 1
In vivo and in vitro regulation of skeletal muscle lipid metabolism
Gabriel, B. M. (2014)
Triglicéridos plasmáticos en pacientes con síndrome coronario agudo.
Torres, M. R., Mejía-Montilla, J., Montero, I. F., Torres-Cepeda, D., Sabatini-Saéz, I., Reyna-Villasmil, N., Reyna‐Villasmil, E., & Velásquez, M. G. (2007) · Actualidad Contable FACES
The effect of prior exercise on postprandial lipaemia
Hurren, N. M. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Fettstoffwechsel, Übergewicht und Ernährung, Diabetes
Böhm, M., Diet, F., Flesch, M., Laufs, U., Nickenig, G., & Schnabel, P. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_14
Intermediate-density lipoprotein as an indipendent risk factor for coronary artery disease
Kurata, T., Mokuno, H., Daida, H., Kanoh, T., & Yamaguchi, H. (1999) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.27.1-2_55
Patch, C. S. (2005) · Research Online (University of Wollongong)
Chapter 29 Mode of action of lipid-lowering drugs
Packard, C. J., & Shepherd, J. (1997) · Principles of medical biology · doi:10.1016/s1569-2582(97)80054-2
Lendner, J. D. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6114
Shami, A. (2014) · Lund University Publications (Lund University)
Longitudinal Change in Serum Cholesterol Levels Among Isolated Hypertriglyceridemic Cases
Kumagai, S., Shibata, H., Watanabe, S., & Suzuki, T. (1996) · Journal of Epidemiology · doi:10.2188/jea.6.178
Xu, N., Dahlbäck, B., Ohlin, A. K., & Nilsson, A. C. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90417-8
Davignon, J. (1997) · Evidence-based Cardiovascular Medicine · doi:10.1016/s1361-2611(97)80027-9
Kaplan, A., Kaplan, S., Marcoe, K. F., Sauvage, L. R., & Hammond, W. P. (1997) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969700300305
Risk of Coronary Artery Disease Homocyst (e)in, Low HDL Cholesterol, Fibrinogen
Chung, I. M. (1998) · Korean Circulation Journal · doi:10.4070/kcj.1998.28.3.471
Ducobu, J. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80691-5
Proinsulin and insulin responses to a mixed meal in hypertriglyceridaemic men.
Gama, R. M., Norris, F., Hampton, S., Morgan, L., Wright, J., & Marks, V. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.8.627
Modulation of Triglyceride Metabolism by Diet and Drugs
Pace, P., Knapp, R. D., Jones, P. H., Pownall, H. J., & Gotto, A. M. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_15
Kasim-Karakas, S. E., Li, Y., Almario, R. U., Temel, İ., & Kenny, T. P. (1999) · Nutrition Research · doi:10.1016/s0271-5317(98)00190-0
Kafonek, S. D., Cloey, T. A., Bachorik, P. S., & Kwiterovich, P. O. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80269-3
Schmidt, E. B., Kristensen, S. D., & Dyerberg, J. (1995) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.4.5.443
Cigarette Smoking and Blood Insulin, Glucose, and Lipids in Young Japanese Women
Yu, K., Imamura, H., Masuda, R., & Noda, Y. (2009) · Eisei kagaku · doi:10.1248/jhs.55.294
Insulin Resistance: What, Why, and How
Reaven, G. M. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_20
Barcellos, L. M. A. (2006) · Americanae (AECID Library)
Pesola, A. J. (2011) · Jyväskylä University Digital Archive (University of Jyväskylä)
Association of Apolipoprotein E Genotype with Early and Advanced Atherosclerotic Lesions
Ilveskoski, E. (2001) · Tampere University Institutional Repository (Tampere University)
Drugs Affecting High-Density Lipoprotein and Triglyceride Metabolism
Gotto, A. M. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_27
Management of Dyslipidaemias The Potential Role of Atorvastatin
Sharpe, N., Simon, A. M., & White, H. J. (1998)
McGladdery, S. H. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0089570
Francis, M. C. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0089732
Perfil lipídico e intensidade de doença Aterosclerótica na Síndrome
Penalva, R., Huoya, M. D. O., Cláudio, L., Correia, L., Feitosa, G. S., Marice, A., & Ladeia, T. (2008)
The Genetics of Lipoprotein Disorders
Davignon, J., Cohn, J. S., Roy, M., & Minnich, A. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_37
Triglycerides are Independently Predictive of the Extent of Coronary Atherosclerosis
Drexel, H., Muntwyler, J., Beran, J., Schmid, H., Gasser, T., & Amann, F. W. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_24
Austin, M. A., & Hokanson, J. E. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_23
Self-citation12. Epidemiology and risk factors of coronary artery disease
Bowker, T. J., Barbir, M., & Ilsley, C. D. J. (1996)
Kusunoki, M., Natsume, Y., Tsutsui, H., Miyata, T., Tsutsumi, K., & Oshida, Y. (2018) · International Journal of Pharmacology · doi:10.3923/ijp.2018.1153.1159
A New Rabbit Strain with Heritable Hypercholesterolemia and Hypertriglyceridemia
Takasaki, S., Zhang, C., Ito, T., & Tomoike, H. (2000) · Springer eBooks · doi:10.1007/978-4-431-68424-4_35
Barter, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50036-6
Shawky, I., Mousa, M. A. M., & Elwaseef, M. S. R. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.38655
The atherogenic lipoprotein phenotype in renal disease
Deighan, C. J. (1999) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.71278
Tunick, M. H. (2010) · Chemical and functional properties of food components series · doi:10.1201/b10272-17
Halder, M. A. S., & De, S. K. (2021) · Indian Journal Of Applied Research · doi:10.36106/ijar/5702089
Triglyceride-Rich Lipoproteins
Le, N., & Brown, W. V. (2000) · doi:10.1007/978-1-4757-9310-9_5
Triglyceride-Rich Lipoproteins
Le, N., & Brown, W. V. (2003) · doi:10.1007/978-1-4615-6484-3_5
DHEA, Obesity and Cardiovascular Disease
Tchernof, A., Labrie, F., & Després, J. (2011) · De Gruyter eBooks · doi:10.1515/9783110811162.191
(2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143840.x
Vegetarian Diets and Dietary Guidelines for Chronic Disease Prevention
Haddad, E. H. (2001) · Modern nutrition · doi:10.1201/9781420036831.ch15
Labrousse, F. (2002) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(02)00046-x
Healthy Food Versus Phytosterol-Fortified Foods for Primary Prevention of Coronary Artery Disease
Matvienko, O., & Lewis, D. (2003) · CRC Press eBooks · doi:10.1201/9780203506332.ch8
KAUR, N., Kaur, J., & KAUR, J. (2023) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2023.v16i4.47038
Ginsberg, H. N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00031-5
Effects of Dose Amount for Antiepileptic Drugs on Lipid Profile of Male Rats (Rattus Norvegicus).
Abbas, A. M. (2017) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v6i2.18
Beson, L. R. (1992) · Defense Technical Information Center (DTIC)
Increased Triglyceride Levels and Cardiovascular Disease
Gotto, A. M. (1992) · Medical science symposia series · doi:10.1007/978-94-011-2700-4_28
Mahdavi‐Roshan, M., Mozafarihashjin, M., Shoaibinobarian, N., Ghorbani, Z., Salari, A., Savarrakhsh, A., & Hekmatdoost, A. (2022) · Figshare · doi:10.6084/m9.figshare.21629338
Matsumoto, I., Wada, K., Kurozumi, M., Namba, T., & Takagi, Y. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.03.011
Björnson, E., & Adiels, M. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01442-y
Effects of Dose Amount for Antiepileptic Drugs on Lipid Profile of Male Rats (Rattus Norvegicus).
(2019) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/vol6/2/13
Is Hypertriglyceridemia always a Risk Factor?
de Man, F. H. A. F., Hoffer, M. J. V., Smelt, A. H. M., Leuven, J. A. G., & van der Laarse, A. (1997) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0037-0_9
De atherogene rol van triglyceriden, LDL- en HDL-subfracties
Swinkels, D. W., & Demacker, P. N. M. (1996) · Radboud Repository (Radboud University)
Epidemiology and risk factors of coronary artery disease
Bowker, T. J., Barbir, M., & Ilsley, C. D. J. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5406-2_12
Weitere kardiovaskuläre Risikofaktoren
Böhm, M., Diet, F., Flesch, M., Laufs, U., Nickenig, G., & Schnabel, P. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_16
Lipoprotein levels following oral fat intake in patients with coronary heart disease
Ditschuneit, H. H. M., Flechtner‐Mors, M., Knispel, D. C., Voisard, R., & Ditschuneit, H. H. M. (1993) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-01942-8_14
Metadata
- Authors
- Austin, M. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Austin, M A
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1991-01
- Volume
- 11
- Issue
- 1
- Pages
- 2-14
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2155238815
- Cited by
- 697
- References
- 98
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 13 · 2012: 8
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29hl038760-03)
- National Heart, Lung, and Blood Institute (HL38760, P01HL030086, HL3-0086)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- plasma triglycerides, coronary artery disease, cardiovascular risk factors, hypertriglyceridemia, familial hypertriglyceridemia, small dense LDL, HDL cholesterol, genetic susceptibility, primary prevention, lipid-lowering intervention
- MeSH terms
- Coronary Disease, Female, Humans, Male, Pedigree, Triglycerides, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review